NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver-Reference-Cited by-同舟云学术

NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver

Published:2003-12 Issue:6 Volume:39 Page:932-939
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Fiorucci Stefano,Antonelli Elisabetta,Brancaleone Vincenzo,Sanpaolo Laura,Orlandi Stefano,Distrutti Eleonora,Acuto Giancarlo,Clerici Carlo,Baldoni Monia,Del Soldato Piero,Morelli Antonio

Publisher

Elsevier BV

Subject

Hepatology

Reference37 articles.

1. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes;Jensen;Gastroenterology,2002

2. Endothelin-1 induces direct constriction of hepatic sinusoids;Zhang;Am J Physiol,1994

3. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance;Rockey;Hepatology,1996

4. Portal vascular responsiveness to sympathetic stimulation and nitric oxide in cirrhotic rats;Mathie;J Hepatol,1996

5. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators;Bhathal;J Hepatol,1985

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology and therapeutic options for cirrhotic portal hypertension;The Lancet Gastroenterology & Hepatology;2024-07

2. Responsive oligochitosan nano-vesicles with ursodeoxycholic acid and exenatide for NAFLD synergistic therapy via SIRT1;Carbohydrate Polymers;2022-07

3. Synthesis and Anti-Hepatoma Activities of U12 Derivatives Arresting G0/G1 Phase and Inducing Apoptosis by PI3K/AKT/mTOR Pathway;Pharmaceuticals;2022-01-17

4. Pathophysiology and Management of Variceal Bleeding;Drugs;2021-03-12

5. Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges;Pharmacology & Therapeutics;2020-08